TNXP vs. APH

Last updated Jun 4, 2026

TNXP (Tonix Pharmaceuticals Holding Corp.) and APH (Amphenol Corporation) are both stocks. TNXP operates in Biotechnology (Healthcare), while APH operates in Electronic Components (Technology). Over the past 10 years, TNXP returned -84.70%/yr vs 27.09%/yr for APH. At a 0.15 correlation, their price movements are largely independent.

Performance

TNXP vs. APH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tonix Pharmaceuticals Holding Corp. (TNXP) and Amphenol Corporation (APH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TNXP achieves a -27.02% return, which is significantly lower than APH's 9.45% return. Over the past 10 years, TNXP has underperformed APH with an annualized return of -84.70%, while APH has yielded a comparatively higher 27.09% annualized return.

TNXP

• 1D: -2.73%
• 1M: -12.51%
• YTD: -27.02%
• 6M: -35.88%
• 1Y: -71.82%
• 3Y*: -87.63%
• 5Y*: -89.37%
• 10Y*: -84.70%

APH

• 1D: -0.53%
• 1M: 4.67%
• YTD: 9.45%
• 6M: 6.89%
• 1Y: 62.16%
• 3Y*: 57.45%
• 5Y*: 34.98%
• 10Y*: 27.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TNXP vs. APH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TNXP Tonix Pharmaceuticals Holding Corp.	-27.02%	-52.64%	-97.44%	-83.46%	-96.59%	-47.01%	-42.31%	-94.68%	-93.62%	-26.61%
APH Amphenol Corporation	9.45%	96.08%	41.30%	31.85%	-11.96%	35.25%	22.09%	34.91%	-6.82%	31.81%

Correlation

The correlation between TNXP and APH is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (10Y) Calculated over the trailing 10-year period	0.17
Correlation (All Time) Calculated using the full available price history since May 11, 2012	0.15

Fundamentals

Market Cap TNXP : $156.26M APH : $190.39B
EPS TNXP : -$11.15 APH : $4.58
PS Ratio TNXP : 6.24 APH : 7.31
PB Ratio TNXP : 0.69 APH : 13.62
Total Revenue (TTM) TNXP : $17.56M APH : $25.90B
Gross Profit (TTM) TNXP : $10.28M APH : $9.67B
EBITDA (TTM) TNXP : -$149.18M APH : $7.45B

Return for Risk

TNXP vs. APH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TNXP

TNXP Risk / Return Rank: 9
TNXP Sharpe Ratio Rank: 8
TNXP Sortino Ratio Rank: 6
TNXP Omega Ratio Rank: 8
TNXP Calmar Ratio Rank: 7
TNXP Martin Ratio Rank: 17

APH

APH Risk / Return Rank: 77
APH Sharpe Ratio Rank: 82
APH Sortino Ratio Rank: 74
APH Omega Ratio Rank: 76
APH Calmar Ratio Rank: 76
APH Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TNXP vs. APH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tonix Pharmaceuticals Holding Corp. (TNXP) and Amphenol Corporation (APH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TNXP	APH	Difference
Sharpe ratio Return per unit of total volatility	-0.81	1.55	-2.36
Sortino ratio Return per unit of downside risk	-1.50	1.98	-3.47
Omega ratio Gain probability vs. loss probability	0.84	1.28	-0.44
Calmar ratio Return relative to maximum drawdown	-0.88	2.22	-3.10
Martin ratio Return relative to average drawdown	-1.13	5.79	-6.92
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TNXP vs. APH - Sharpe Ratio Comparison

The current TNXP Sharpe Ratio is -0.81, which is lower than the APH Sharpe Ratio of 1.55. The chart below compares the historical Sharpe Ratios of TNXP and APH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TNXP	APH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.81	1.55	-2.36
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.66	1.16	-1.81
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.60	0.98	-1.58
Sharpe Ratio (All Time) Calculated using the full available price history	-0.58	0.63	-1.22

Drawdowns

TNXP vs. APH - Drawdown Comparison

The maximum TNXP drawdown since its inception was -100.00%, which is greater than APH's maximum drawdown of -63.41%. Use the drawdown chart below to compare losses from any high point for TNXP and APH.

Drawdown Indicators

	TNXP	APH	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-63.41%	-36.59%
Max Drawdown (1Y) Largest decline over 1 year	-81.48%	-28.19%	-53.29%
Max Drawdown (3Y) Largest decline over 3 years	-99.88%	-28.19%	-71.69%
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	-28.73%	-71.27%
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	-37.56%	-62.44%
Current Drawdown Current decline from peak	-100.00%	-11.03%	-88.97%
Average Drawdown Average peak-to-trough decline	-91.16%	-13.56%	-77.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	63.70%	10.76%	+52.94%

Volatility

TNXP vs. APH - Volatility Comparison

Tonix Pharmaceuticals Holding Corp. (TNXP) has a higher volatility of 25.96% compared to Amphenol Corporation (APH) at 15.91%. This indicates that TNXP's price experiences larger fluctuations and is considered to be riskier than APH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TNXP	APH	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.96%	15.91%	+10.05%
Volatility (6M) Calculated over the trailing 6-month period	52.37%	36.03%	+16.34%
Volatility (1Y) Calculated over the trailing 1-year period	88.75%	40.39%	+48.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	136.01%	30.42%	+105.59%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	140.91%	27.75%	+113.16%

Dividends

TNXP vs. APH - Dividend Comparison

TNXP has not paid dividends to shareholders, while APH's dividend yield for the trailing twelve months is around 0.56%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
APH Amphenol Corporation	0.56%	0.55%	0.79%	1.07%	1.06%	0.89%	0.80%	0.89%	1.09%	0.80%	0.86%	1.01%
TNXP Tonix Pharmaceuticals Holding Corp.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both TNXP and APH in my portfolio?

TNXP and APH have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TNXP or APH?

TNXP has higher volatility (25.96%) compared to APH (15.91%). In terms of maximum drawdown, TNXP dropped -100.00% vs APH's -63.41%.

Which has better risk-adjusted returns?

APH currently has the higher Sharpe Ratio (1.55 vs -0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.